monotherapy

0:02:03

Focus on Kidney: End of Monotherapy

0:01:23

I-O monotherapy for advanced NSCLC

0:00:46

Dr. Ho on First-Line TKI Monotherapy in mRCC

0:15:22

Spravato: First FDA-Approved Monotherapy for Treatment-Resistant Depression

0:13:24

PRO: Monotherapy Using 6-MP or Azathioprine for IBD is Dead

0:02:52

HCG Monotherapy vs Clomid Monotherapy vs TRT - TMHC vlog

0:02:25

Clomid Monotherapy

0:03:12

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type | Dr George Dangas

0:06:40

Evaluating I-O Monotherapy’s Value in Treating mRCC

0:01:55

Durvalumab monotherapy for patients with BCG-unresponsive carcinoma-in-situ bladder cancer

0:02:18

Comparing the efficacy of TKI monotherapy versus TKIs with IO in nccRCC

0:11:15

Breaking Boundaries: Ticagrelor Monotherapy in High-Risk Patients | Dr. Bhupesh Shah | TRICO 2025

0:03:16

ICI Combination Therapy Versus Monotherapy

0:05:50

Monotherapy Versus Combination Therapy Approaches in Melanoma

0:05:06

PARP inhibitor monotherapy

0:01:15

Why androgen deprivation monotherapy is no longer considered to be standard of care treatment

0:01:55

Mosunetuzumab monotherapy demonstrates durable efficacy with a manageable safety profile in R/R FL

0:06:01

Studying the Benefits of monotherapy and Combined Therapies in Diabetes

0:01:47

The Rationale for Dostarlimab Monotherapy In MSI-H and MSS Endometrial Cancer

0:02:29

Accure - 1st Acne Monotherapy by Laser

0:09:24

Anti-PD1 monotherapy or combination with ipi after BRAF/MEK inhibitors in BRAF-mutant melanoma

0:02:20

JAK inhibition in MF: monotherapy versus combination treatment

0:01:15

ADT monotherapy for treatment of metastatic hormone-sensitive disease

0:04:18

Pembrolizumab monotherapy for older/ABVD-ineligible patients with Hodgkin lymphoma